Global medical markets for oncology and vascular therapies projected to grow

Global medical markets for oncology treatments, diagnostics, and specialized interventions are projected to see significant growth through the early 2030s.

The hematologic oncology drug market is expected to grow from USD 74.6 billion in 2025 to USD 138.8 billion by 2032, driven by high-cost innovative therapies. The market remains concentrated, with the top ten companies accounting for approximately 81% of sales. Concurrently, the hematopoietic stem cell transplantation market is forecasted to reach USD 8.57 billion by 2030, supported by advancements in gene-modified cell therapies and expanding transplant infrastructure.

In the diagnostic sector, the histology market is projected to rise from USD 8.9 billion in 2026 to USD 14.5 billion by 2031, fueled by the rising burden of chronic diseases and the adoption of precision medicine. Additionally, the peripheral vascular intervention product market is expected to grow from approximately USD 81.7 billion in 2025 to USD 131.18 billion by 2032, as aging populations increase the prevalence of peripheral artery disease and deep vein thrombosis.